Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call for Analysts and Investors22-04-2021
22-04-2021
Syngene International Ltd - 539268 - Shareholding for the Period Ended March 31, 2021
Syngene International Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here20-04-2021
Syngene International Ltd - 539268 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- PRIYADARSHINI MAHAPATRADesignation :- Company Secretary and Compliance Officer16-04-2021
Syngene International Ltd - 539268 - Sub: Half Yearly Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
With reference to the above subject, please find enclosed Half Yearly Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 issued by S Anand SS Rao, Company Secretary in Practice for the half- year ended on March 31, 2021. Kindly take the above document on record and acknowledge.15-04-2021
Biocon opens vaccination centre at Syngene for people in Electronic City
Biocon Group on Monday opened Covid-19 vaccination centre at its Bengaluru campus of Syngene International Limited, as part of the nationwide drive fo12-04-2021
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated April 06, 2021 regarding Notice of the Board Meeting, please find enclosed herewith the copy of newspaper advertisement published in the Financial Express (All India Edition) and Vijayavani (Bengaluru Edition) on April 07, 2021.07-04-2021
Syngene International Ltd - 539268 - Board Meeting Intimation for Intimation Of Board Meeting And Trading Window Closure
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2021 ,inter alia, to consider and approve Pursuant to regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, April 27, 2021, inter alia, to consider and approve the Audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2021. Pursuant to the above, the trading window for dealing in securities of the Company for all Insiders, as defined under the Code of Conduct for Prevention of Insider Trading of the Company, has been closed from April 01, 2021 to April 29, 2021 (both days inclusive) in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The Company will organize a conference call for analysts and investors on Wednesday, April 28, 2021. The details of the same will be available on the Company's website closer to the scheduled event.06-04-2021
Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.05-04-2021
Syngene International Ltd - 539268 - Half Yearly Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015, For The Half Year Ended On March 31, 2021.
Half Yearly Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015, for the half year ended on March 31, 2021. Kindly take the above document on record and acknowledge.05-04-2021
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Acquisition
In terms of Regulation 30 of SEBI Listing Regulations, we wish to inform you that the Company has been informed on March 31, 2021, of the conversion of Compulsorily Convertible Debentures of Immuneel Therapeutics Private Limited into equity shares resulting in acquisition of 7.78 % shareholding in the latter. Other details as required to be disclosed under aforesaid Regulation 30 read with clause 1 of Para A of Annexure I of SEBI Circular dated September 9, 2015, are enclosed as 'Annexure A'. Kindly take the same on record. The above-mentioned information will also be available on the website of the Company www.syngeneintl.com. We request you to kindly take this information on record and oblige.01-04-2021